Table 2.

Statin Experience and Willingness to Try a Cholesterol‐Lowering Medication Among Those Previously Not Receiving a Statin

Variable	Those Aged ≤75 y	Those Aged >75 y	P Valuea
Among those currently receiving a statin (n=4641)
Experienced any symptoms	1519 (46.6)	446 (41.3)	0.003
Experienced myalgias	1083 (33.3)	294 (27.3)	<0.001
Among those currently receiving a high‐intensity statin (n=1358)
Experienced any symptoms	493 (48.2)	89 (35.3)	<0.001
Experienced myalgias	352 (34.5)	49 (19.5)	<0.0001
Among those previously receiving a statin (n=525)
Reason for stopping
No longer needed	68 (18.6)	27 (18.9)	0.95
Did not like taking daily	23 (6.3)	3 (2.1)	0.07
Cost/expense or lost/changed insurance	30 (8.2)	6 (4.2)	0.11
Did not notice improvement	18 (4.9)	3 (2.1)	0.21
Prefer natural remedies	28 (7.7)	7 (4.9)	0.27
Adverse effects	195 (53.4)	83 (58.0)	0.35
Friend/relative/other information suggested stopping	22 (6.0)	6 (4.2)	0.42
Do not know/cannot remember	38 (10.4)	15 (10.5)	0.98
Among those who were never receiving a statin (n=1551)
Ever recommended (% yes)	137 (18.8)	45 (18.2)	0.83
Willingness to try a cholesterol‐lowering medication
Not at all or unlikely	89 (16.7)	38 (20.4)	0.02
Possibly	173 (32.5)	46 (24.7)
Very likely or almost certainly	233 (43.8)	78 (41.9)
Do not know	37 (7.0)	24 (12.9)

Data are presented as number (percentage), with the percentage generated as a percentage of the number of patients in that particular age (≤75 vs >75 years old) and statin treatment status subgroup (currently receiving a statin, currently receiving a high‐intensity statin, previously receiving a statin, or never receiving a statin). All percentages were calculated as a percentage of nonmissing.

^aχ² Tests were used when the cell number was ≥5. Fisher's exact tests were used when the cell number was <5.